Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Autoimmunity appears to be increasing in the U.S.

Autoimmunity, a condition in which the body's immune system reacts with components of its own cells, appears to be increasing in the United States, according to scientists at the National Institutes of Health and their collaborators.

8 Apr 2020

Promise in reversing kidney damage caused by lupus shown by cancer drug

A drug used for cancer therapy has shown promise in reversing kidney damage caused by systemic lupus erythematosus.

8 Apr 2020

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

For 10 days last month, they lay in side-by-side isolation units in a Seattle-area hospital, tethered to oxygen and struggling to breathe as the coronavirus ravaged their lungs.

6 Apr 2020

‘Staying away from grandma’ isn’t an option in multigenerational homes

The Walker family never thought having an age range of 3 to 96 under the same roof would be risky.

6 Apr 2020

Who should be taking antimalarial drugs as treatment against COVID-19?

Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.

2 Apr 2020

Studies shed light on the link between obesity and use of prescription opioids

Two new studies from the Boston University School of Public Health shed light on the relationship between obesity and the use of prescription opioids in the United States.

2 Apr 2020

UIC participates in two clinical trials for COVID-19 treatments

The University of Illinois at Chicago is participating in two clinical trials for COVID-19 treatments.

2 Apr 2020

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

Amid the coronavirus disease (COVID-19) pandemic, many theories have emerged about the disease and the treatments that can in supportive care. A recent theory emerged that suggests non-steroidal anti-inflammatory drugs (NSAIDs) might exacerbate the symptoms of the novel coronavirus. Now, a new study shows that there is no evidence for or against the use of NSAIDS, particularly ibuprofen, for patients with COVID-19.

1 Apr 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

Total-body PET provides suitable images of antibodies up to 30 days after injection

Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.

31 Mar 2020

Individuals taking glucocorticoids are at high risk if infected with COVID-19

Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

31 Mar 2020

NIH researchers identify a second gene that causes melorheostosis

Researchers at the National Institutes of Health have discovered a second gene that causes melorheostosis, a rare group of conditions involving an often painful and disfiguring overgrowth of bone tissue.

31 Mar 2020

IOF-FFN agreement sets framework for greater collaborative efforts worldwide

The health burden represented by osteoporosis and fragility fractures is growing rapidly at the global level, largely due to ageing demographics.

31 Mar 2020

New study helps identify drugs that are safe for treating COVID-19

A recent study has found that there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen for patients with COVID-19.

31 Mar 2020

Temple researchers reverse muscle fibrosis associated with overuse injury in animals

Overuse injuries - think muscle strains, tennis elbow, and rotator cuff tears - are a considerable problem in the United States, especially among young athletes.

30 Mar 2020

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.

30 Mar 2020

EULAR launches database to monitor and report outcomes of COVID-19 in patients with RMDs

The European League Against Rheumatism launches a European pediatric and adult database to monitor and report outcomes of COVID-19 occurring in patients with rheumatic and musculoskeletal diseases with the support of the Global Rheumatology Alliance.

27 Mar 2020

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows.

26 Mar 2020

FDA approves immune-modulating therapy for treatment of multiple sclerosis

The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis.

26 Mar 2020

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Autoimmunity appears to be increasing in the U.S.

Promise in reversing kidney damage caused by lupus shown by cancer drug

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

‘Staying away from grandma’ isn’t an option in multigenerational homes

Who should be taking antimalarial drugs as treatment against COVID-19?

Studies shed light on the link between obesity and use of prescription opioids

UIC participates in two clinical trials for COVID-19 treatments

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

Total-body PET provides suitable images of antibodies up to 30 days after injection

Individuals taking glucocorticoids are at high risk if infected with COVID-19

NIH researchers identify a second gene that causes melorheostosis

IOF-FFN agreement sets framework for greater collaborative efforts worldwide

New study helps identify drugs that are safe for treating COVID-19

Temple researchers reverse muscle fibrosis associated with overuse injury in animals

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

EULAR launches database to monitor and report outcomes of COVID-19 in patients with RMDs

UC Davis launches two clinical trials to evaluate treatments for COVID-19

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

FDA approves immune-modulating therapy for treatment of multiple sclerosis

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in